ArticleScientific reports2026

Comparative pharmacoinformatic and quantum descriptor insights from BFM/GBTLI guidelines to phase I/II compounds for acute lymphoblastic leukemia (ALL).

Ian A F Bahia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.